Market Value349,991,000
Total Holdings69
File Date2021-05-10
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NTRA / Natera, Inc.
REPL / Replimune Group, Inc.
EHC / Encompass Health Corporation
GWP / GW Pharmaceuticals plc
AKRO / Akero Therapeutics, Inc.
NSTG / NanoString Technologies, Inc.
GMED / Globus Medical, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
EHTH / eHealth, Inc.
SGFY / Signify Health Inc - Class A
VRTX / Vertex Pharmaceuticals Incorporated
CYTK / Cytokinetics, Incorporated
ZNTL / Zentalis Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
DNLI / Denali Therapeutics Inc.
JNJ / Johnson & Johnson
PODD / Insulet Corporation
ALEC / Alector, Inc.
PNTG / The Pennant Group, Inc.
AVTX / Avalo Therapeutics, Inc.
PGNY / Progyny, Inc.
DTIL / Precision BioSciences, Inc.
CRL / Charles River Laboratories International, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
MSON / Misonix Inc
HMIN / Homeinns Hotel Group
KDMN / Kadmon Holdings Inc
MDT / Medtronic plc
KZR / Kezar Life Sciences, Inc.
KURA / Kura Oncology, Inc.
RLAY / Relay Therapeutics, Inc.
EXEL / Exelixis, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
ARNA / Arena Pharmaceuticals Inc
RARE / Ultragenyx Pharmaceutical Inc.
ABT / Abbott Laboratories
AXNX / Axonics, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
LHCG / LHC Group Inc
RVTY / Revvity, Inc.
HZNP / Horizon Therapeutics Plc
KPTI / Karyopharm Therapeutics Inc.
AGIO / Agios Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
BCRX / BioCryst Pharmaceuticals, Inc.
AERI / Aerie Pharmaceuticals Inc
CCXI / ChemoCentryx Inc
BHVN / Biohaven Ltd.
ZBH / Zimmer Biomet Holdings, Inc.
BIIB / Biogen Inc.
ALLO / Allogene Therapeutics, Inc.
MYOV / Myovant Sciences Ltd
ARWR / Arrowhead Pharmaceuticals, Inc.
ABBV / AbbVie Inc.
NVST / Envista Holdings Corporation
SWAV / Shockwave Medical, Inc.
CVS / CVS Health Corporation
TVTX / Travere Therapeutics, Inc.
MGTA / Magenta Therapeutics Inc
MRTX / Mirati Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
DHR / Danaher Corporation
NTLA / Intellia Therapeutics, Inc.
ARDX / Ardelyx, Inc.
CNC / Centene Corporation
THC / Tenet Healthcare Corporation
HCA / HCA Healthcare, Inc.
MRK / Merck & Co., Inc.
GH / Guardant Health, Inc.
FATE / Fate Therapeutics, Inc.
COR / Cencora, Inc.
MGNX / MacroGenics, Inc.
LH / Labcorp Holdings Inc.
BMY / Bristol-Myers Squibb Company
PTCT / PTC Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
RETA / Reata Pharmaceuticals Inc - Class A
NVRO / Nevro Corp.
TFX / Teleflex Incorporated
LLY / Eli Lilly and Company
ALNY / Alnylam Pharmaceuticals, Inc.
INSM / Insmed Incorporated
MCK / McKesson Corporation
BDX / Becton, Dickinson and Company
ELV / Elevance Health, Inc.
ACHC / Acadia Healthcare Company, Inc.
AVTR / Avantor, Inc.